
VNRX VolitionRx LimitedStock Price & Overview
Stock Price & Overview
$0.47
VNRX Stock Price
Quant Ranking
VNRX Analysis










VNRX News
Latest Headlines
Ratings Summary
People Also Follow
Similar to VNRX
ETFs Holding VNRX
VNRX Company Profile
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and diseases associated with NETosis such as sepsis in the United States and internationally. It offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis such as sepsis; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes. VolitionRx Limited is based in Henderson, Nevada.
VNRX Revenue
VNRX Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Growth
Profitability
Momentum
Capital Structure
Dividends
VNRX Ownership
VNRX Peers
Risk
Technicals
VNRX Transcripts
Investor Presentations
VNRX SEC Filings
Press Releases
VNRX Income Statement
VNRX Balance Sheet
VNRX Cash Flow Statement
VNRX Long Term Solvency
Discover More
You may be interested in: